These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
480 related items for PubMed ID: 25841942
1. A comparative approach between heterologous prime-boost vaccination strategy and DNA vaccinations for rabies. Borhani K, Ajorloo M, Bamdad T, Mozhgani SH, Ghaderi M, Gholami AR. Arch Iran Med; 2015 Apr; 18(4):223-7. PubMed ID: 25841942 [Abstract] [Full Text] [Related]
2. DNA vaccine for rabies: relevance of the trans-membrane domain of the glycoprotein in generating an antibody response. Rath A, Choudhury S, Batra D, Kapre SV, Rupprecht CE, Gupta SK. Virus Res; 2005 Nov; 113(2):143-52. PubMed ID: 15978691 [Abstract] [Full Text] [Related]
3. A DNA vaccine that encodes rabies virus glycoprotein lacking transmembrane domain enhances antibody response but not protection. Gupta PK, Sharma S, Walunj SS, Patil AA, Rai A, Saini M. Acta Virol; 2006 Nov; 50(2):87-92. PubMed ID: 16808325 [Abstract] [Full Text] [Related]
4. Enhancing comparative rabies DNA vaccine effectiveness through glycoprotein gene modifications. Osinubi MO, Wu X, Franka R, Niezgoda M, Nok AJ, Ogunkoya AB, Rupprecht CE. Vaccine; 2009 Nov 27; 27(51):7214-8. PubMed ID: 19925956 [Abstract] [Full Text] [Related]
5. A sindbis virus replicon-based DNA vaccine encoding the rabies virus glycoprotein elicits immune responses and complete protection in mice from lethal challenge. Saxena S, Dahiya SS, Sonwane AA, Patel CL, Saini M, Rai A, Gupta PK. Vaccine; 2008 Dec 02; 26(51):6592-601. PubMed ID: 18848857 [Abstract] [Full Text] [Related]
6. Recombinant canine distemper virus serves as bivalent live vaccine against rabies and canine distemper. Wang X, Feng N, Ge J, Shuai L, Peng L, Gao Y, Yang S, Xia X, Bu Z. Vaccine; 2012 Jul 20; 30(34):5067-72. PubMed ID: 22698451 [Abstract] [Full Text] [Related]
7. A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice. Li J, Faber M, Papaneri A, Faber ML, McGettigan JP, Schnell MJ, Dietzschold B. Virology; 2012 Jul 20; 356(1-2):147-54. PubMed ID: 16938327 [Abstract] [Full Text] [Related]
8. Rabies DNA vaccine encoding lysosome-targeted glycoprotein supplemented with Emulsigen-D confers complete protection in preexposure and postexposure studies in BALB/c mice. Kaur M, Saxena A, Rai A, Bhatnagar R. FASEB J; 2010 Jan 20; 24(1):173-83. PubMed ID: 19741168 [Abstract] [Full Text] [Related]
9. A recombinant rabies vaccine expressing the trimeric form of the glycoprotein confers enhanced immunogenicity and protection in outbred mice. Koraka P, Bosch BJ, Cox M, Chubet R, Amerongen Gv, Lövgren-Bengtsson K, Martina BE, Roose J, Rottier PJ, Osterhaus AD. Vaccine; 2014 Aug 06; 32(36):4644-50. PubMed ID: 24962755 [Abstract] [Full Text] [Related]
10. Engineering of a recombinant trivalent single-chain variable fragment antibody directed against rabies virus glycoprotein G with improved neutralizing potency. Turki I, Hammami A, Kharmachi H, Mousli M. Mol Immunol; 2014 Feb 06; 57(2):66-73. PubMed ID: 24091293 [Abstract] [Full Text] [Related]
11. Construction and immunogenicity of a recombinant pseudotype baculovirus expressing the glycoprotein of rabies virus in mice. Huang H, Xiao S, Qin J, Jiang Y, Yang S, Li T, Gao Y, Li Z, Li T, Su X, Ruan Y, Xu F, Wang H, Chen H, Xia X. Arch Virol; 2011 May 06; 156(5):753-8. PubMed ID: 21221673 [Abstract] [Full Text] [Related]
12. Nanogram quantities of plasmid DNA encoding the rabies virus glycoprotein protect mice against lethal rabies virus infection. Ray NB, Ewalt LC, Lodmell DL. Vaccine; 1997 Jun 06; 15(8):892-5. PubMed ID: 9234541 [Abstract] [Full Text] [Related]
13. One-time intradermal DNA vaccination in ear pinnae one year prior to infection protects dogs against rabies virus. Lodmell DL, Ewalt LC, Parnell MJ, Rupprecht CE, Hanlon CA. Vaccine; 2006 Jan 23; 24(4):412-6. PubMed ID: 16153757 [Abstract] [Full Text] [Related]
14. Comparison of different prime-boost regimes with DNA and recombinant Orf virus based vaccines expressing glycoprotein D of pseudorabies virus in pigs. van Rooij EM, Rijsewijk FA, Moonen-Leusen HW, Bianchi AT, Rziha HJ. Vaccine; 2010 Feb 17; 28(7):1808-13. PubMed ID: 20018271 [Abstract] [Full Text] [Related]
15. Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and cats. Ge J, Wang X, Tao L, Wen Z, Feng N, Yang S, Xia X, Yang C, Chen H, Bu Z. J Virol; 2011 Aug 17; 85(16):8241-52. PubMed ID: 21632762 [Abstract] [Full Text] [Related]
16. Enhanced immune responses to E2 protein and DNA formulated with ISA 61 VG administered as a DNA prime-protein boost regimen against bovine viral diarrhea virus. Cai D, Song Q, Duan C, Wang S, Wang J, Zhu Y. Vaccine; 2018 Sep 05; 36(37):5591-5599. PubMed ID: 30077483 [Abstract] [Full Text] [Related]
17. A new rabies vaccine based on a recombinant ORF virus (parapoxvirus) expressing the rabies virus glycoprotein. Amann R, Rohde J, Wulle U, Conlee D, Raue R, Martinon O, Rziha HJ. J Virol; 2013 Feb 05; 87(3):1618-30. PubMed ID: 23175365 [Abstract] [Full Text] [Related]
18. Induction of protective immunity by topic application of a recombinant adenovirus expressing rabies virus glycoprotein. Lees CY, Briggs DJ, Wu X, Davis RD, Moore SM, Gordon C, Xiang Z, Ertl HC, Tang DC, Fu ZF. Vet Microbiol; 2002 Apr 02; 85(4):295-303. PubMed ID: 11856579 [Abstract] [Full Text] [Related]
19. Comparison of the immunogenicity of two inactivated recombinant rabies viruses overexpressing the glycoprotein. Navid MT, Li Y, Zhou M, Cui M, Fu ZF, Tang L, Zhao L. Arch Virol; 2016 Oct 02; 161(10):2863-70. PubMed ID: 27438075 [Abstract] [Full Text] [Related]
20. Rabies virus glycoprotein and immune response pattern using recombinant protein or recombinant RNA viral vectors. Astray RM, Ventini DC, Boldorini VL, Silva FG, Rocca MP, Pereira CA. Vaccine; 2014 May 19; 32(24):2829-32. PubMed ID: 24598721 [Abstract] [Full Text] [Related] Page: [Next] [New Search]